← Back to headlines
Ariel Global Fund Re-Adds Bristol-Myers Squibb (BMY) Citing Pipeline Strength and Valuation
The Ariel Global Fund has re-added Bristol-Myers Squibb Company (BMY) to its portfolio, citing the company's strong pipeline and attractive valuation as key factors.
31 Mar, 12:04 — 31 Mar, 12:04
Sources
Showing 1 of 1 sources
